Method for separating mitochondria in eukaryotic cells
Through screening of forward scattered light signals and side scattered light signals in hypotonic solution or ultrasonic lysis combined with flow cytometry, high-purity separation of mitochondria and nucleus in eukaryotic cells is achieved, and sample loss and operation in the prior art is solved Complex problems improve separation accuracy and are suitable for micro samples.
Patent Information
- Application Number
- CN202411271325.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art has large sample loss, complex operation, long time, and problems of nuclear plasmid contamination and mitochondria contamination when isolating mitochondria in eukaryotic cells, making it difficult to achieve high-precision mitochondrial separation and nucleus separation.
Hypotonic solution or ultrasound lysed cell membranes, and screened mitochondria with forward scattered light signals and side scattered light signals, combined with SYBR Green dye for labeling and flow cytometry sorting to achieve synchronous high purity of mitochondria and cell nucleus. Separation.
Accurate capture of mitochondria and nucleus is achieved in low-concentration cell samples, reducing sample loss, simplifying operation, improving separation accuracy, suitable for micro-clinical puncture samples, and promoting the genetic and molecular mechanism analysis of mitochondria-related diseases.
Smart Images

Figure CN119020263A_ABST
Abstract
Description
Technical Field
[0001] The present application belongs to the field of biotechnology, and more specifically, relates to a method for isolating mitochondria in eukaryotic cells. Background Art
[0002] Human mitochondrial DNA (mtDNA) is a maternally inherited circular double-stranded DNA consisting of approximately 16,569 bp, encoding 37 genes, 22 transfer RNAs and 2 ribosomal RNAs. It is the second largest independent source of genomic information in the cell besides the nucleus. These encoded products are mainly involved in the intracellular oxidative respiratory chain and transport-related proteins. Due to the lack of histone protection and the lack of damage repair system, the mutation rate of the mitochondrial genome is significantly higher than that of nuclear genome DNA (ncDNA). There are hundreds to thousands of copies of mitochondrial DNA in each cell. There are huge differences in the content of mitochondrial DNA in different cell types and tissue cells. Cellular coordination of mitochondrial DNA content is a dynamic and strictly regulated process. The abundance of mitochondria in the same type of cells under different states is also dynamically regulated. However, the maintenance and response mechanism of mitochondrial DNA copy number in cells is still unclear. Existing studies have shown that in the transition from a healthy state to a diseased state, the level of mitochondrial DNA in cells usually changes significantly with key pathophysiological changes, including aging-related diseases, cardiovascular diseases, diabetes, tumors, etc. Typical mitochondrial-based diseases also include myoclonic epilepsy with irregular red fibers (MERRF), mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) syndrome, and Leber hereditary optic neuropathy (LHON).
[0003] When the mtDNA in a cell mutates, wild-type mtDNA and mutant mtDNR will coexist in the same cell, resulting in mitochondrial heteroplasmy. Mitochondrial heteroplasmy is considered to be an important cause of mitochondrial-related diseases. It is generally believed that the severity of mitochondrial diseases is related to the percentage of mutant mitochondrial DNA in specific cells and tissues. The molecular mechanisms of intracellular mitochondrial replication, distribution, maintenance and dynamic control of mitochondrial numbers, allocation of mutant mitochondria to offspring, and realization of threshold effects are currently poorly understood. This greatly limits the prevention and treatment of mitochondrial-related diseases. Current mitochondrial genome analysis mainly relies on high-throughput sequencing technology and bioinformatics analysis. However, there are a large number of nuclear genome mitochondrial sequences (NUMTs) in the nuclear genome, which increases the complexity of mitochondrial assembly. NUMTs are sequence fragments that are highly similar to mitochondrial genome genes and are widely present in the nuclear genome. There are hundreds to thousands of NUMTs in the human nuclear genome, accounting for 0.87% of the length of the human nuclear genome. Simply using total DNA as a template to obtain DNA sequences through high-throughput sequencing technology, and then performing mitochondrial genome sequence mining and splicing to obtain mitochondrial genome information has the possibility of a certain degree of nuclear genome contamination, and there is uncertainty about the accuracy and reliability of the sequence.
[0004] The integrity and homeostasis of the mitochondrial proteome are the basis for the normal functioning of mitochondria. Mammalian mitochondria contain about 1,500 proteins, which are encoded by the nuclear genome and the mitochondrial genome. Among them, the mitochondrial genome encodes 13 proteins, and most of the remaining mitochondrial proteins are encoded by the nuclear genome. After transcription, translation and modification in the cytoplasm, they enter specific locations of mitochondria with the help of the mitochondrial protein transport system to perform their functions. Accurately capturing the mitochondrial proteome in different cell states is a key technical means to conduct mitochondrial function research.
[0005] At present, the method of obtaining a complete mitochondrial proteome relies almost entirely on various differential centrifugation or ultracentrifugation techniques. Through density gradient centrifugation technology, the separation of different organelles is obtained according to the differences in the sedimentation coefficients of different organelles, and then the complete mitochondria are obtained. Relying on this method, scientists have gained a broad and in-depth understanding of the mitochondrial proteome. However, using the organelle separation method based on centrifugation technology, cell lysis mainly relies on mechanical shearing methods such as homogenizer homogenization, and the sample loss is large. For a small number of clinical puncture samples, mitochondrial separation operations cannot be carried out. At the same time, this method is complex to operate, has high technical requirements, is time-consuming, and organelles with similar sedimentation coefficients have co-purification phenomena. In addition, existing mitochondrial and nuclear separation technologies, especially mitochondrial separation technologies, generally use grinding and other methods for separation, which inevitably forms nuclear cytoplasmic contamination in the mitochondrial component, and mitochondrial contamination in the nuclear component, and the separation accuracy is not high. Summary of the invention
[0006] In response to the above defects or improvement needs of the prior art, the present application provides a direct and visual mitochondrial separation and purification technology suitable for a small number of eukaryotic cells, the purpose of which is to achieve accurate capture of mitochondria.
[0007] To achieve the above object, according to one aspect of the present application, a method for isolating mitochondria in eukaryotic cells is provided, comprising the following steps:
[0008] S1. Lysing cell membranes of eukaryotic cells in a cell suspension, and labeling mitochondria with a first dye to obtain a suspension of labeled organelles, wherein the organelles include mitochondria;
[0009] Wherein, the first stain is ethidium bromide, bisbenzimidazole trihydrochloride, DAPI, SYBR Green or propidium iodide;
[0010] S2. According to the forward scattered light signal and the side scattered light signal of the labeled organelle, a screening interval of the flow cytometer is set for the organelle, and the organelle is obtained using the screening interval.
[0011] Preferably, the concentration of eukaryotic cells in the cell suspension is 10 2 pcs / ml~10 5 Pieces / ml.
[0012] Preferably, in step S1, the cell nucleus is further labeled with a second dye, the cell organelle also includes the cell nucleus, and the second dye is a mitochondrial membrane potential cationic dye or SYBR Green; the cell organelle obtained in step S2 is isolated mitochondria and isolated cell nuclei.
[0013] As further preferred, the first dye and the second dye are SYBR Green.
[0014] As further preferred, the second dye is a mitochondrial membrane potential cationic dye. In the step S1, the cell membranes of eukaryotic cells in the cell suspension are firstly lysed, and then the cell nuclei are marked with the second dye.
[0015] As further preferred, in the step S1, the concentration of the first dye and the second dye in the cell suspension is 0.05 μmol / L to 0.1 μmol / L.
[0016] Preferably, the eukaryotic cell is a mammalian cell.
[0017] Preferably, the cell membrane lysis method is hypotonic solution lysis and / or ultrasonic lysis.
[0018] As further preferred, the cell membrane lysis method is hypotonic solution lysis, specifically: incubating eukaryotic cells with a hypotonic buffer having a pH value of 7.3 to 7.6 for 15 minutes to 45 minutes.
[0019] As further preferred, the hypotonic buffer comprises 0.001 mol / L to 0.01 mol / L of ethylenediaminetetraacetic acid and 0.002 mol / L to 0.02 mol / L of tris(hydroxymethyl)aminomethane hydrochloride.
[0020] As further preferred, the method for cell membrane lysis is ultrasonic lysis, specifically: using ultrasound with a power of 100W to 350W and a frequency of 10KHZ to 60KHZ to treat the cell suspension for 5min to 120min.
[0021] In general, compared with the prior art, the above technical solution conceived by the present application can sort mitochondria in eukaryotic cells within 10 2 ~10 5 The mitochondria of cells can be screened out at a low concentration of 100 / ml; and the cell nucleus and mitochondria can be screened simultaneously to obtain high-purity mitochondrial and cell nucleus populations;
[0022] For a large number of clinical puncture samples or rare samples, this application establishes a direct, visual, synchronous separation and purification technology of mitochondria and nuclei at the organelle level, which is applicable to a small number of cells, and achieves the refined capture of mitochondria and nuclei, which can greatly promote the analysis of the genetic and molecular mechanisms of mitochondrial-related diseases and provide assistance for the further development of treatment methods for mitochondrial diseases;
[0023] This method can synchronously separate mitochondria and cell nuclei for trace cell samples, and has the technical characteristics of being safe, environmentally friendly, simple and reliable, widely applicable, with a high success rate and high precision. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a microscopic observation picture of the mitochondria and nuclei of THP-1 cells after staining in Example 1 of the present application; wherein red fluorescence indicates mitochondria, and blue fluorescence indicates nuclei;
[0025] Figure 2 This is a microscopic observation picture of free mitochondria and cell nuclei after ultrasonic lysis of cells in Example 1 of the present application; wherein red fluorescence indicates mitochondria, and blue fluorescence indicates cell nuclei;
[0026] Figure 3 This is a microscopic observation picture of free mitochondria and cell nuclei after ultrasonic lysis of cells labeled with SYBR in Example 1 of the present application;
[0027] Figure 4a This is a flow analysis picture of Example 1 of the present application, where P1 represents the total particle group to be analyzed;
[0028] Figure 4b The peak area of the side scattered light signal (SSC) is plotted against the peak height for Example 1 of the present application, where P2 represents a single particle population with adhesion removed;
[0029] Figure 4c The peak area of the forward scattered light signal (FSC) was plotted against the peak height. P4 represents the single particle population without adhesion bodies;
[0030] Figure 4d These are flow cytometry images of mitochondria and nuclei; the nuclei gate represents the nuclear particle population, and the mitochrondria gate represents the mitochondrial particle population;
[0031] Figure 5 This is a microscopic observation picture of mitochondria recovered by flow sorting in Example 1 of the present application;
[0032] Figure 6 This is a microscopic observation picture of the cell nuclei recovered by flow sorting in Example 1 of the present application;
[0033] Figure 7 This is the result of mitochondrial and single-cell nuclear genome amplification in Example 1 of this application. DETAILED DESCRIPTION
[0034] In order to make the purpose, technical solutions and advantages of the present application more clearly understood, the present application is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not intended to limit the present application. In addition, the technical features involved in each embodiment of the present application described below can be combined with each other as long as they do not conflict with each other.
[0035] The present application discloses a method for isolating mitochondria in eukaryotic cells, including the steps of lysing cell membranes and staining and sorting organelles; taking the simultaneous sorting of mitochondria and cell nuclei as an example, the specific steps are as follows:
[0036] S1. Lyse the cell membrane with a hypotonic solution and / or ultrasound, and add a first dye and a second dye to stain the mitochondria and nucleus in the cell organelles respectively;
[0037] Among them, the standard of cell membrane lysis is that the organelles cannot be destroyed; when using a hypotonic solution (usually a solution with an osmotic pressure lower than that of plasma) for lysis, the eukaryotic cells are incubated for 15 minutes to 45 minutes using a hypotonic buffer with a pH value of 7.3 to 7.6. For example, a solution including 0.001 mol / L to 0.01 mol / L ethylenediaminetetraacetic acid and 0.002 mol / L to 0.02 mol / L tris(hydroxymethyl)aminomethane hydrochloride can be selected as a hypotonic buffer; when using ultrasonic lysis, the cell suspension can be treated with ultrasound with a power of 100 W to 350 W and a frequency of 10 KHZ to 60 KHZ for 5 minutes to 120 minutes; a hypotonic solution can also be used first and then ultrasonic lysis, as long as the time and intensity are controlled to the extent of lysing the cell membrane without destroying the organelles; in some embodiments, the concentration of eukaryotic cells in the cell suspension is 10 2 pcs / ml~10 5 / ml. If hypotonic buffer is used for lysis, the concentration refers to the concentration after adding hypotonic buffer. If ultrasonic lysis is used, it refers to the original concentration.
[0038] The first dye used for staining is ethidium bromide, bisbenzimidazole trihydrochloride, DAPI (4',6-diamidino-2-phenylindole), SYBR Green or propidium iodide; the second dye is a mitochondrial membrane potential cationic dye (the corresponding excitation wavelength and receiving wavelength are both 488nm) or SYBR Green (the corresponding excitation wavelength is 488nm, and the receiving wavelength is 525nm); in some embodiments, the first dye and the second dye are both SYBR Green, so that only one dye needs to be added to achieve staining of two organelles; the concentrations of the first dye and the second dye can refer to the instructions for use of the dyes. In some embodiments, the concentrations of the first dye and the second dye are in the range of 0.05μmol / L to 0.1μmol / L;
[0039] Staining can be performed before or after cell membrane lysis, but when the second dye is a mitochondrial membrane potential cationic dye, the second dye needs to be performed after cell membrane lysis to label the cell nucleus;
[0040] S2. Centrifuge the suspension of the labeled organelles at 1000-2000rpm for 3-10 minutes to remove excess first dye and second dye; observe the forward scattered light signal and side scattered light signal distribution range of the nucleus and mitochondria respectively through the forward scattered light signal and side scattered light signal of the labeled organelle; since the volume of the nucleus and mitochondria differs by 5-10 times, there is a significant difference in the scattered light signal, and there must be a large difference in the range of the two; according to the observed forward scattered light signal and side scattered light signal distribution range, set the screening interval of the flow cytometer for the organelle, and obtain the organelle using the screening interval; the light intensity displayed in the flow cytometer is relative light intensity, and the screening interval is different for samples of different types, different batches, different concentrations or different flow cytometers, and needs to be reset; the minimum detectable particle of the flow cytometer should be no less than 0.5 microns, and the minimum detectable FITC signal intensity should be no less than 30MESF;
[0041] When only mitochondria need to be screened and cell nuclei do not need to be screened, the steps of staining the cell nuclei and setting the screening intervals in the above steps can be omitted, that is, only separated mitochondria can be obtained from the screened organelles in the end.
[0042] In order to better lyse the cell membrane, before the step S1, the biological material containing eukaryotic cells may also be pretreated to be suitable for biofilm lysis, which specifically includes washing, freezing or freeze-thawing, drying, grinding, mechanical shearing, enzyme or chemical reagent treatment of the biological material; in some embodiments, the biological material may include at least one of animal and plant individuals, tissues, organs and symbionts, blood and artificially cultured or isolated cells, and the biological material also includes one or more of microbial groups including fungi, protozoa, etc. The biological material also includes a variety of biological materials containing mitochondrial genomes or mixed biological samples of soil, sediment, plant rhizosphere, etc.; in some embodiments, the biological material is preferably a mammalian biological material.
[0043] In some embodiments, before step S1, the cell suspension needs to be pre-treated, which is specifically: centrifuging the conventionally cultured eukaryotic cells at 1000-2000 rpm for 3-10 minutes, discarding the supernatant; then suspending and rinsing with sterile saline or PBS buffer, and then centrifuging again at 1000-2000 rpm for 3-10 minutes; adjusting the cell concentration to 10 with saline or PBS buffer. 2 pcs / ml~10 5 Pieces / ml.
[0044] In some embodiments, the step S1 and step S2 further include centrifugation at 1000-2000 rpm for 3-10 minutes to remove excess mitochondrial-specific dye.
[0045] In some embodiments, the method of obtaining the organelle using the screening interval in step S2 specifically includes:
[0046] S21. Turn on a flow cytometer with a single cell sorting function, preferably a Beckman Coulter Moflo XDP flow cytometer or a Cytoflex SRT flow cytometer, the flow cytometer is equipped with 405nm, 488nm and 638nm lasers; the flow cytometer follows the standard operating procedures of conventional flow cytometers; the sheath fluid is one of 0.9-1.5% sterile phosphate buffer, sodium chloride solution, etc., and the sheath fluid pressure is 20psi-30psi; unstained cells are used as negative controls, and the flow signal negative interval is set accordingly;
[0047] S22. Dilute the sonicated cells 5-fold with commercially available sterile saline or 1×PBS buffer, then take 2 ml of the sample into a sterile flow tube for flow cytometry analysis; use one or more flow cytometry fluorescence signals of mitochondrial and nuclear binding dyes such as propidium iodide, Mito tracker deepred, SYBR green and DAPI as analysis standards, and use the typical differences in mitochondrial and nuclear scattered light signals to analyze the populations in the sample to achieve separation of mitochondrial and nuclear populations;
[0048] S23. Use flow cytometry to sort mitochondrial particles and nuclear particles according to the flow signal population. The number of samples collected in each sorting tube is 1 to 10. 5 Each sorting tube is pre-filled with 20 μl of organelle lysis buffer.
[0049] In some embodiments, after step S2, step S3 is further included: purifying the collected organelles, specifically including:
[0050] The organelle genome separation reagent includes one or more sodium dodecyl sulfate, Tween-20, NP-40 and TritonX-100 surfactants with a final concentration of 0.1-5%, 0.001mol / L-0.1mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH=7.5), 0.001mol / L-0.2mol / L ethylenediaminetetraacetic acid, 0.1mol / L-1mol / L sodium acetate, 0.1mol / L-0.5mol / L potassium acetate; 0.001mol / L-0.1mol / L sodium citrate, 0.01-0.1mol / L tris(hydroxymethyl)aminomethane acetate, 0.001-0.01mol / L ethylenediaminetetraacetic acid, 0.02mol / L sodium acetate, 0.5-5% sodium dodecyl sulfate, 1-5μg / μL proteinase K;
[0051] Place the sorting tube obtained by flow sorting in a 50°C water bath for 3-10 minutes; then add one volume of isopropanol, mix well, place in a -20°C refrigerator, and let stand for 5-20 minutes; then centrifuge at 10000-15000rpm for 10-20 minutes; remove the supernatant, and the resulting precipitate is the purified mitochondrial or nuclear genomic DNA.
[0052] The present application is described in detail below in conjunction with the examples. It should be noted that the examples of the present application are limited to the description of the present application and have no limiting effect. The relevant screening methods, buffer preparations and common culture medium formulas involved in the examples can refer to the contents described in "Molecular Cloning Experiment Guide" (see J. Sambrook et al., 2002, Molecular Cloning Experiment Guide, the third edition, Jin Dongyan et al. (translation), Science Press, Beijing). Various other experimental operations involved in the present application are routine techniques in the art, and there is no special description in the text. Those of ordinary skill in the art can refer to various commonly used reference books, scientific and technological literature or related instructions, manuals, etc. before the application date of the present application for implementation. The operation, quality control and analysis methods of the flow cytometer and flow sorter involved in the present application can be operated and processed according to the standardized guidelines provided by the equipment manufacturer.
[0053] Example 1
[0054] Step 1: Cell culture and specific staining of mitochondria and nuclei
[0055] Cell culture and specific staining of mitochondria and nuclei are performed using standards in the field or recommended methods of various dye suppliers. In this embodiment, human monocytic leukemia cell line THP-1 is used as an example. First, the culture medium is placed in a 37°C incubator for preheating for 30 minutes. Then, the cells are inoculated into a cell culture bottle containing 5 ml of serum-free RPMI-1640 culture medium and placed in a 37°C incubator for culture for 24 to 48 hours. Microscopic observation is performed every 12 hours. The cells are rounded and vigorous in growth as the most suitable state. In this embodiment, 48 hours are cultured. When the cell density is too large, it is necessary to perform subculture. For other adherent cells and trace tissues, the material can be referred to for mechanical or enzymatic single cellization, and the single cell suspension is obtained and then operated according to this embodiment.
[0056] Step 2 Observation of mitochondria and nuclei
[0057] Take out the appropriate amount of single cell suspension obtained in step 1 into a 1.5 ml centrifuge tube, centrifuge at 1000rpm for 5 minutes to collect the cells; then wash three times with serum-free RPMI-1640 medium, and then suspend the cells with serum-free medium, with a final volume of 0.1-0.5 mL, which is 0.1 ml in this embodiment. In order to illustrate the suspension of organelles, DAPI that specifically binds to the nucleus and Mitotracker deep red dye that specifically binds to mitochondria are added to the suspended cells, and the added concentrations are 0.1 μM respectively, and placed in a 37°C incubator for incubation for 15-30 minutes, which is 15 minutes in this embodiment; collect the cells by centrifugation, remove the dye, and suspend the cells with PBS buffer or serum-free medium to a final volume of 0.1-0.5 mL, which is 0.2 ml in this embodiment. Figure 1 This is a microscopic observation picture of THP-1 cells. The cell nucleus in the cell shows blue fluorescence after combining with DAPI, and the mitochondria show red fluorescence after being labeled with Mitotracker deep red, indicating that the organelles are still intact after the cell membrane is lysed. It should be added that the staining fluorescence here was not used as a basis for subsequent flow cytometry screening.
[0058] The stained cells were placed in a cell culture dish and then placed in an ultrasonic cleaning machine for ultrasonic treatment. The ultrasonic power was 100 to 350 watts, the frequency was 10 kHz to 60 kHz, and the ultrasonic time was 5 to 90 seconds. The power used in this embodiment was 120 watts, the frequency was 40 kHz, and the time was 30 seconds. The ultrasonically treated samples were placed under a fluorescence microscope for observation. Figure 2 As shown, the cell membrane is completely lysed, the nucleus and other organelles are released, and the diameter of the nucleus is about 10 to 15 microns; there are almost no cells with cell membranes in the entire field of view, indicating that the cell membranes of all cells in the lysis system are almost completely lysed, while the nucleus remains intact. At the same time, the mitochondria labeled with Mitotracker deep red show obvious red fluorescence, and the mitochondria exist in different short rods or linear forms, with a length of about 1 to 4 microns.
[0059] Step 3: Simultaneous sorting of mitochondria and nuclei
[0060] Similarly, the single cell suspension obtained in step 1 was taken into a 1.5 ml centrifuge tube again and centrifuged at 1000 rpm for 5 min to collect the cells; then the cells were washed three times with serum-free RPMI-1640 medium, and then the cells were suspended with serum-free medium to a final volume of 0.1 to 0.5 ml, 0.1 ml in this embodiment, and the cell concentration was 10 4 The collected cells were stained with about 0.1 μM SYBR green dye and then ultrasonicated in the same way as in step 2. The labeling results are shown in Figure 3 As shown in the figure, mitochondria and cell nuclei exhibit bright green fluorescence under 488nm excitation conditions, and the size of mitochondria is about 1-4μm, and the size of cell nuclei is about 10-15μm, and the fluorescence is stable. After synchronous labeling of mitochondria and cell nuclei, although they have the same fluorescence, there are significant differences in their individual sizes. Subsequent experiments will use SYBR green dye to synchronously label mitochondria and cell nuclei for flow cytometric analysis and flow sorting.
[0061] Dilute the mixed sample of nuclei and mitochondria successfully labeled with SYBR green to 0.2-2 ml with sterile PBS or saline to a final particle concentration of 10 3 ~10 7 / ml, the volume diluted in this example is 0.2 ml, and the final concentration is 10 6 / ml. Then add it to a sterile flow tube as a flow sorting sample. Add 50 microliters of sterile sheath fluid to the particle collection tube. If the collection tube is a 96-well plate, add 10 microliters of sterile sheath fluid to each well for use.
[0062] First, according to the requirements of the high-sensitivity flow cytometer equipment, a sheath fluid with a suitable osmotic pressure is selected. In this embodiment, sterile physiological saline is used as the flow sorting sheath fluid. According to the technical requirements of the Beckman flow cytometer Cytoflex SRT, the analysis conditions of the flow cytometer are optimized, and a suitable gate is established to control the sheath fluid pressure at 25 to 30 psi. First, the Cytoflex SRT is systematically calibrated using the flow sorter calibration reagent of Beckman Korla. At the same time, unlabeled cell lysate is used as a negative control sample, and SYBR green labeled samples are used as positive control samples for flow analysis to establish the positive interval and negative space of the fluorescent signal for labeling mitochondria and nuclei.
[0063] In order to carry out the simultaneous sorting and separation of mitochondria and nuclei based on flow sorting technology, it is first necessary to achieve complete separation of the nuclear particle group and the mitochondrial particle group in the flow signal. According to the inherent characteristics of the significant difference in particle size between mitochondria and nuclei, there are significant differences in the forward scattering light signal (FS, the machine is the scattering light signal excited at 488nm) and the side scattering light signal (SS, the machine is the scattering light signal excited at 488nm) of the flow; at the same time, SYBR green specifically binds to subcellular organelles containing double-stranded DNA molecules. Therefore, based on these two characteristics, we draw a map with SSC vs FITC signal channels, where the excitation wavelength of FITC is 488nm and the receiving wavelength is 525nm, which can be distinguished into two distinct independent "cell groups (particle groups)".
[0064] As shown in Figure 4, Figure 4a This is a flow cytometric graph of a micro-organelle sample after gentle lysis under the scattered light signal channel, in which free nuclei and mitochondrial particles account for about 66.56%; in flow data processing, the peak area of the same signal channel is usually used to process the peak height to obtain the single particle population under the signal channel and exclude adhesion bodies, such as Figure 4b and Figure 4c As shown. Figure 4a The side scattered light signal (SSC) and forward scattered light signal (FSC) of the free nucleus and mitochondria particle group P1 are processed to obtain the single particle group in this case; the single particle group without adhesion in the side scattered light signal channel in the P1 group accounts for about 97.21%, which is defined as the P2 group, such as Figure 4b As shown; further, the P2 population accounts for about 72.64% of the single particle population in the forward scattered light signal channel, and is named P4, as shown Figure 4c As shown. The fluorescence signals of the free single mitochondria and nucleus populations indicated by P4 are analyzed. In the flow chart with the FITC channel signal as the horizontal coordinate and the SSC signal as the vertical coordinate (it should be noted that the values of the FITC signal and the SSC signal marked on the coordinates are relative values), the P4 population forms two relatively concentrated particle groups, of which the upper right area group is the nucleus population (nuclei), accounting for 3.89%; the lower left area is the mitochondria population (mitochrondria), accounting for 84.81%. Finally, according to the setting of the flow cytometer, the L1 and R1 two-way sorting modes are selected, where L1 corresponds to the nucleus population; R1 corresponds to the mitochondria population, and the nuclear particle signals and mitochondrial particle signals in the sample are sorted synchronously. According to the actual work needs, single particle sorting can be selected, that is, only one particle is received in each collection tube, and the number of collected particles can also be arbitrarily defined. Then, using the flow sorting function, the mitochondrial particle group and the nuclear particle group are synchronously sorted at high speed. It should be pointed out that due to the small size of mitochondrial particles, a necessary condition for the implementation of this application is that the minimum detectable particle of the device should be no less than 0.5 microns and the minimum detectable FITC signal intensity should be no less than 30MESF.
[0065] For particle group sorting, the number of collected nuclei is not less than 5,000, and the number of collected mitochondria is not less than 50,000; for single nucleus sorting, one nucleus or one mitochondria is sorted in each well. After sorting, the obtained nuclei and mitochondria particles are placed under a fluorescence microscope for microscopic observation. As shown, according to the operation of this embodiment, complete mitochondria can be obtained through flow sorting, such as Figure 5 As shown, and the nucleus as Figure 5As shown, the fluorescent dye was maintained and the particle state was clear. No mitochondrial particles were found in the recovered cell nuclei, and no nuclear particles appeared in the recovered mitochondrial population, which shows that the mitochondrial and cell nucleus sorting based on this method has the advantages of high purity, fast speed, and precise and controllable quantity.
[0066] According to the same steps of Example 1, the concentration of suspended cells and the concentration of SYBR green dye added when staining suspended cells with SYBR green dye in step 3 were adjusted. It was found that when the cell concentration was 10 2 ~10 5 When the dye concentration is 0.05 μmol / L to 0.1 μmol / L, the effect of recovering mitochondrial particles and cell nuclei similar to that in Example 1 can be obtained.
[0067] Experimental results verify mitochondrial and nuclear single-molecule amplification
[0068] According to the mitochondrial genome information and the human genome sequence information, the purity analysis of the mitochondrial genome is performed according to the following specific primers or probes. It should be pointed out that the purpose of this embodiment is to analyze whether the isolated mitochondria contaminate the cell nucleus, and whether the isolated cell nucleus contaminates the mitochondria. Therefore, any mitochondrial genome-specific probe and cell nuclear genome-specific probe designed or selected can be applied to this verification method. This verification example is implemented using the following specific probe sequence as an example.
[0069] Mitochondrial genome specific primers or probes are:
[0070] ND1F:AAC ATA CCC ATG GCC AAC CT
[0071] ND1R:AGC GAA GGG TTG TAG TAG CCC
[0072] The primers for specific amplification of the nuclear genome are:
[0073] NcoA3F:GAGTTTCCTGGACAAATGAG
[0074] NcoA3R:CATTGTTTCATATCTCTGGCG
[0075] Prepare the PCR system according to the following table:
[0076]
[0077] Mitochondrial genome DNA (mtDNA) was amplified by PCR using the above-mentioned mitochondrial genome specific primers (ND1F, ND1R) and nuclear genome specific amplification primers (NcoA3F, NcoA3R) at the same time. The amplification procedure is as follows:
[0078] Pre-denaturation at 95°C for 10 minutes;
[0079] 94°C, 30 seconds
[0080] 60℃, 30 seconds
[0081] 34 cycles
[0082] 25℃, 5 minutes
[0083] At the same time, the same PCR amplification reaction was also carried out on nuclear genomic DNA (nDNA).
[0084] The results are as follows Figure 7 As shown, in the mitochondrial part recovered based on flow sorting technology, the amplification product of the mitochondrial genome-specific fragment can be clearly obtained, while no nuclear genome amplification product appears; at the same time, in the nuclear component, the NcoA3 fragment is successfully amplified, while the ND1 fragment unique to the mitochondrial genome cannot be amplified. This shows that there is no nuclear genome contamination in the mitochondrial components recovered simultaneously based on this application, and there is no mitochondrial genome contamination in the nuclear genome. The nucleus and mitochondria are synchronously and accurately separated and recovered with high purity, fast speed and no interference.
[0085] It will be easily understood by those skilled in the art that the above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application shall be included in the scope of protection of the present application.
Claims
1. A method for isolating mitochondria in eukaryotic cells, characterized in that: The following steps are involved: S1. Lysing cell membranes of eukaryotic cells in a cell suspension, and labeling mitochondria with a first dye to obtain a suspension of labeled organelles, wherein the organelles include mitochondria; Wherein, the first stain is ethidium bromide, bisbenzimidazole trihydrochloride, DAPI, SYBR Green or propidium iodide; S2. According to the forward scattered light signal and the side scattered light signal of the labeled organelle, a screening interval of the flow cytometer is set for the organelle, and the organelle is obtained using the screening interval.
2. The method according to claim 1, characterized in that In the step S1, the cell nucleus is also labeled with a second dye, the cell organelle also includes the cell nucleus, and the second dye is a mitochondrial membrane potential cationic dye or SYBR Green; the cell organelles obtained in the step S2 are isolated mitochondria and isolated cell nuclei.
3. The method according to claim 2, characterized in that The first dye and the second dye are SYBR Green.
4. The method according to claim 2, characterized in that The second dye is a mitochondrial membrane potential cationic dye. In the step S1, the cell membranes of the eukaryotic cells in the cell suspension are first lysed, and then the cell nuclei are marked with the second dye.
5. The method according to claim 2, characterized in that In the step S1, the concentration of the first dye and the second dye in the cell suspension is 0.05 μmol / L to 0.1 μmol / L.
6. The method according to claims 1 to 5, characterized in that The eukaryotic cells are mammalian cells.
7. The method according to claims 1 to 5, characterized in that The cell membrane lysis method is hypotonic solution lysis and / or ultrasonic lysis.
8. The method according to claim 7, characterized in that The cell membrane lysis method is hypotonic solution lysis, specifically: using a hypotonic buffer solution with a pH value of 7.3 to 7.6 to incubate the eukaryotic cells for 15 minutes to 45 minutes.
9. The method according to claim 8, characterized in that The hypotonic buffer comprises 0.001 mol / L to 0.01 mol / L of ethylenediaminetetraacetic acid and 0.002 mol / L to 0.02 mol / L of tris(hydroxymethyl)aminomethane hydrochloride.
10. The method according to claim 7, characterized in that The cell membrane lysis method is ultrasonic lysis, specifically: using ultrasound with a power of 100W to 350W and a frequency of 10KHZ to 60KHZ to treat the cell suspension for 5min to 120min.
Citation Information
Cited By
Rapid pit mud aging detection method
CN120539027A
